Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPressure Tech Regulatory News (PRES)

  • There is currently no data for PRES

Board Appointments

21 Mar 2023 07:05

RNS Number : 5981T
Pressure Technologies PLC
21 March 2023
 

21 March 2023

Pressure Technologies plc

("Pressure Technologies" or "the Company")

Board Appointments

Pressure Technologies plc, (AIM: PRES), the specialist engineering group, announces that Richard Staveley will be appointed as a Non-Executive Director of the Company following the publication of its Annual Report & Accounts for the financial year ended 1 October 2022, which the Company currently expects to be no later than the end of April 2023.

Richard is a qualified accountant who has over twenty years' experience of equity investing, fund management and working with both private and publicly quoted companies. Having qualified as a Chartered Accountant at PricewaterhouseCoopers, Richard has worked in a senior capacity and fund manager at a number of successful fund management businesses, including Majedie Asset Management and was a co-founder of River and Mercantile Asset Management. He is a Chartered Financial Analyst (CFA) Charterholder and holds a Bachelor of Arts degree in politics from the University of Newcastle. Richard is a Non-Executive Director of AIM quoted Bonhill Plc, and Centaur Media plc, a company listed on the main market of the London Stock Exchange.

Richard Staveley is a consultant to Harwood Capital LLP ("Harwood"), the investment manager of Rockwood Strategic plc, which holds 20.04 percent of the Company's issued share capital, and is being appointed as a representative of Harwood pursuant to a Relationship Agreement between the Company, Harwood and the Company's nominated adviser. The primary purpose of the Relationship Agreement is to ensure that the Company is capable of carrying on its business independently at all times. In accordance with the terms of the Relationship Agreement, Mr Staveley shall be entitled to remain on the Board of Directors of the Company provided that Harwood retains an aggregate interest of at least 10% of the Company's issued ordinary share capital.

On 17 January 2023, the Company announced the appointment of Steve Hammell as Chief Financial Officer, which was expected to be in the second quarter of this calendar year. The Company now confirms that Steve will join the Company as a Director in May 2023.

Further announcements will be made regarding the appointment dates for both Directors in due course, as appropriate.

Nick Salmon, Chair of Pressure Technologies, commented on the appointments:

"We are appreciative of the support the Company has from key shareholders and Richard's appointment further demonstrates this. We are delighted that Richard will be joining the Board and believe his knowledge of the business and considerable investment experience will be invaluable.

We are pleased that Steve will also be joining the Board, where his considerable financial knowledge and industry experience will contribute significantly to the development of the business."

Regulatory disclosures

In accordance with Schedule 2(g) of the AIM Rules for Companies, Richard Adam Staveley (aged 48) is, or has been within the previous five years, a director or partner of the following companies or partnerships:

Current directorships/partnerships

Past directorships/partnerships

Wildblood Ltd

Centaur Media plc

Bonhill Plc

 

None

Richard Staveley does not have any beneficial interest in the Company's issued share capital. There is no further information to be disclosed pursuant to Schedule 2(g) of the AIM Rules for Companies.

Regulatory disclosures for Steve Hammell were made in the Company's announcement on 17 January 2023.

For further information, please contact:

Pressure Technologies plc

Chris Walters, Chief Executive

 

Tel: 0330 015 0710

PressureTechnologies@houston.co.uk

Singer Capital Markets (Nomad and Broker)

Rick Thompson / Asha Chotai

Tel: 0207 496 3000

Houston (Financial PR and Investor Relations)

Kay Larsen / Ben Robinson

Tel: 0204 529 0549

COMPANY DESCRIPTION

 www.pressuretechnologies.com

With its head office in Sheffield, the Pressure Technologies Group was founded on its leading market position as a designer and manufacturer of high-integrity, safety-critical components and systems serving global supply chains in oil and gas, defence, industrial and hydrogen energy markets.

The Group has two divisions, Chesterfield Special Cylinders and Precision Machined Components.

Chesterfield Special Cylinders (CSC) - www.chesterfieldcylinders.com

● Chesterfield Special Cylinders, Sheffield, includes CSC Deutschland GmbH.

Precision Machined Components (PMC) - www.pt-pmc.com

● Precision Machined Components includes the Al-Met, Roota Engineering and Martract sites.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUAAWUPWPWU
Date   Source Headline
7th Jun 20117:00 amRNSAnalyst Briefing
4th May 201110:43 amRNSHolding in Company
28th Apr 20114:35 pmRNSIssue of Equity and Total Voting Rights
21st Apr 201112:51 pmRNSHolding in Company
21st Apr 20117:00 amRNSNotice of Results and Trading Update
4th Apr 20117:00 amRNSBiogas Upgrade Licence Extension
31st Mar 201111:19 amRNSTotal Voting Rights
24th Mar 201112:37 pmRNSIssue of Equity, Director's Shareholding and TVR
3rd Mar 20117:00 amRNSIssue of Equity and Total Voting Rights
10th Feb 20112:56 pmRNSResult of AGM 2011
10th Feb 20117:00 amRNSTrading Update
24th Jan 20117:00 amRNSAGM and Site Tour
13th Dec 20101:57 pmRNSHolding(s) in Company
10th Dec 20103:06 pmRNSHolding(s) in Company
8th Dec 20103:15 pmRNSConfirmation of AGM Date
7th Dec 20107:00 amRNSPreliminary Results 2010
29th Nov 20107:00 amRNSNotice of Results and Analyst Briefing
18th Oct 20107:00 amRNSAcquisition of Hydratron and Trading Update
15th Oct 20104:32 pmRNSDirector's Interest
5th Oct 20101:00 pmRNSFirst injection of Biomethane into National Grid
27th Sep 20107:00 amRNSChesterfield BioGas at EBEC 2010
13th Sep 20109:14 amRNSHolding(s) in Company
6th Sep 20108:51 amRNSHolding(s) in Company
2nd Sep 20102:25 pmRNSHolding(s) in Company
31st Aug 201010:55 amRNSHolding(s) in Company
26th Aug 20102:32 pmRNSHolding(s) in Company
23rd Aug 201012:04 pmRNSHolding(s) in Company
2nd Aug 20108:39 amRNSHolding(s) in Company
2nd Aug 20107:00 amRNSMajor Orders for UK Naval Projects
29th Jul 20108:45 amRNSHolding(s) in Company
23rd Jul 20103:54 pmRNSDirector/PDMR Shareholding
23rd Jul 20101:38 pmRNSHolding(s) in Company
14th Jun 20107:00 amRNSInterim Results 2010
11th Jun 20105:37 pmRNSHolding(s) in Company
7th Jun 20107:00 amRNSCHESTERFIELD BIOGAS WINS FIRST MAJOR ORDER
26th May 20107:00 amRNSAnalyst Briefing
12th Apr 20107:00 amRNSNotice of Results and Pre-Close Trading Statement
2nd Mar 20101:03 pmRNSHolding(s) in Company
2nd Mar 201012:59 pmRNSHolding(s) in Company
2nd Mar 201012:56 pmRNSHolding(s) in Company
23rd Feb 20109:15 amRNSDirector/PDMR Shareholding
10th Feb 20102:13 pmRNSResult of AGM 2010
8th Feb 20107:01 amRNSAcquisition of Al-Met Limited
8th Feb 20107:00 amRNSTrading Update
14th Dec 20094:25 pmRNSHolding(s) in Company
8th Dec 20097:00 amRNSPreliminary Results 2009
3rd Dec 20097:00 amRNSNotice of Results and Analyst Briefing
6th Nov 20097:00 amRNSChange of Adviser
16th Oct 200911:56 amRNSHolding(s) in Company
7th Oct 20094:52 pmRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.